3DBiotech, additive manufacturing in regenerative medicine

3D bioprinting has revolutionized the medical sector by providing advanced treatments that improve the quality of surgical interventions. In fact, we already analyzed the advantages of additive manufacturing for personalised medicine, and saw the various 3D printing technologies that could be used in different areas. 3DBiotech, located in Córdoba is dedicated to the research and development of solutions for several medical sectors. In addition, they have obtained surgical results through additive manufacturing technologies by generating models that are made for the anatomy of patients – enabling successful surgical planning . We were curious how 3DBiotech makes use of 3D printing for the development of its solutions, and in particular in regenerative medicine. Therefore, we interviewed one of its experts, Eduardo Espinosa.

3DN: Could you introduce yourself and tell us about your relationship with 3D printing technologies?

My name is Eduardo Espinosa, head of the R+D+i Department at 3DBiotech. The first contact, at personal level, with 3D printing I had it in a technological center (RISE PFI As) in Trondheim (Norway) where I realized a stay of investigation during my doctorate. During this period we worked with hydrogels to create structures that could be used in 3D bioprinting or 3D printing of medical solutions for wound treatment. From this experience, and once inside 3DBiotech, I have worked with a wider spectrum of technologies and materials for 3D printing focused mainly on the dental and hospital sector.

3DN: Could you tell us more about 3DBiotech?

Well, 3DBiotech is a technology-based company that bases its raison d’être on the development of integral digital CAD/CAM solutions for the dental and hospital sector. The project arises from the growing development of this type of solutions in the hospital sector and the market niche that has been generated in recent years. 3DBiotech already had a wide experience in the implementation of these solutions in the dental sector, which has been the pioneer clinical sector in the adaptation of this type of solutions to its day to day, and wanted to extrapolate all this know-how and previous development to the hospital and biomedical sector.